SCHEMBL3665313

SCHEMBL3665313

CCCCCCCCCCCOc1ccccc1C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.74
MEN1 O00255 2/20 0.74
LMNA P02545 2/20 0.74
CYP3A4 P08684 2/20 0.74
NR1I2 O75469 1/20 0.74
CHRM2 P08172 1/20 0.74
ADRA2A P08913 1/20 0.74
MAPT P10636 1/20 0.74
OPRK1 P41145 1/20 0.74
HTR2B P41595 1/20 0.74
SLC6A3 Q01959 1/20 0.74
HDAC6 Q9UBN7 1/20 0.74
PTPN11 Q06124 6/20 0.68
ALDH1A1 P00352 4/20 0.65
PTK2B Q14289 1/20 0.65
NPSR1 Q6W5P4 1/20 0.62
KDM4E B2RXH2 1/20 0.60
RECQL P46063 1/20 0.60
PTPN1 P18031 3/20 0.60
S1PR3 Q99500 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL342176 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL2044840 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL18140779 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL18141371 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL1274781 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL527254 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL6575990 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL168816 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL112985 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2
SCHEMBL1005992 1.00 KMT2A (0.74) KMT2AMEN1LMNACYP3A4NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1806384-B1 ENHANCED BORON NITRIDE COMPOSITION AND COMPOSITIONS MADE THEREWITH GEN ELECTRIC (US) 2017-10-25 EP claimed
US-7524560-B2 Enhanced boron nitride composition and compositions made therewith MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-04-28 US claimed
EP-1806384-A1 Enhanced boron nitride composition and compositions made therewith General Electric Company (US) 2007-07-11 EP claimed
US-20070054122-A1 Low viscosity; surface treatment; calcination; spray drying slurry; heat treatment; thermoconductivity; electronics GENERAL ELECTRIC COMPANY (US) 2007-03-08 US claimed
WO-2004062607-A2 USE OF WEAK ACIDS OR THEIR PRECURSORS FOR THE TREATMENT OF TUBERCULOSIS (TB) AND DRUG RESISTANT TB ZHANG YING (US) 2004-07-29 WO claimed
US-10428194-B2 Modified acrylic resin cured product, and laminate thereof, and production methods therefor MITSUI CHEMICALS, INC. (JP) 2019-10-01 US disclosed
EP-3263635-B1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR MITSUI CHEMICALS INC (JP) 2019-09-18 EP disclosed
US-20180163056-A1 HYDROPHILIC CURABLE COMPOSITIONS MITSUI CHEMICALS, INC. (JP) 2018-06-14 US disclosed
US-20180036995-A1 HYDROPHILIC MONOLAYER FILM WITH OPTICAL FUNCTIONALITY AND STACK OF THE SAME MITSUI CHEMICALS, INC. (JP) 2018-02-08 US disclosed
US-20180030230-A1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR MITSUI CHEMICALS, INC. (JP) 2018-02-01 US disclosed
EP-3270192-A1 HYDROPHILIC SINGLE-LAYER FILM HAVING OPTICAL FUNCTIONALITY, AND LAMINATE THEREOF Mitsui Chemicals, Inc. (JP) 2018-01-17 EP disclosed
EP-3263635-A1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR Mitsui Chemicals, Inc. (JP) 2018-01-03 EP disclosed
EP-1806384-A1 Enhanced boron nitride composition and compositions made therewith General Electric Company (US) 2007-07-11 EP disclosed
US-20070054122-A1 Low viscosity; surface treatment; calcination; spray drying slurry; heat treatment; thermoconductivity; electronics GENERAL ELECTRIC COMPANY (US) 2007-03-08 US disclosed
EP-1702907-A2 Enhanced boron nitride composition and polymer-based compositions made therewith GENERAL ELECTRIC COMPANY (US) 2006-09-20 EP disclosed
WO-2004062607-A2 USE OF WEAK ACIDS OR THEIR PRECURSORS FOR THE TREATMENT OF TUBERCULOSIS (TB) AND DRUG RESISTANT TB ZHANG YING (US) 2004-07-29 WO disclosed
EP-0592904-A1 Topical stable compositions with good active agent release capability and containing at least a lipophilized macrolide antibiotic Röhm Pharma GmbH (DE) 1994-04-20 EP disclosed
US-5187202-A Cellulosic short fiber or floc and dispersant aid FERRO CORPORATION (US) 1993-02-16 US disclosed
EP-0308977-A2 Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1989-03-29 EP disclosed
EP-0239444-A1 Ferroelectric liquid crystal, process for its manufacture and its use in a liquid-crystal mixture THOMSON-CSF (FR) 1987-09-30 EP disclosed